TMLEP Clinical Updates
TMLEP’s Clinical Updates are provided in order to raise awareness of clinical risk issues and to reduce incidence recurrence and improve patient safety. Facts have been anonymised to maintain data confidentiality, however learning points remain applicable.
To receive notifications as soon as new updates become available, please enter your details in the form below or follow TMLEP’s Twitter or LinkedIn feeds (accessible at the top of the page).
“Whilst we wait for a cure, could Baricitinib act as a potential treatment for 2019-nCoV acute respiratory disease?” TMLEP Member, Justin Stebbing explores.18 March 2020
TMLEP Member, Justin Stebbing and his team research Baricitinib as a potential treatment for 2019-nCoV.
Clinical Risk Case Study- Inpatient Fall Prevention16 March 2020
TMLEP would like to highlight the importance of identifying patients at risk of falls and then managing their time in hospital accordingly.
A Clinical Risk Case Study- Recognising Crohn’s Disease Red Flags12 March 2020
TMLEP would like to highlight the importance of recognising red flags of Crohn’s disease, following through with investigations and correctly reviewing tests. Signs of Crohn’s disease must not be ignored, and unexpected results should cause clinicians to consider re-testing or alternate investigations.
A Clinical Risk Case Study- The Importance of Appropriate Risk Assessments Before Prescription05 March 2020
TMLEP would like to highlight how important it is to consider each patient individually and assess the potential risks in light of the individual’s clinical presentation, age, gender and other clinical factors such as test results.